SCHEMBL6583906

SCHEMBL6583906

Cc1ccc(CC(=O)N(C)C)c(O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.44
TRPA1 O75762 1/20 0.42
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CSNK2A1 P68400 1/20 0.39
MPL P40238 1/20 0.38
MAPT P10636 2/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
PCNA P12004 1/20 0.38
ALOX15 P16050 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
AMY1A P0DUB6 1/20 0.37
ICMT O60725 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
ALB P02768 1/20 0.37
CYP3A4 P08684 1/20 0.37
CHRM1 P11229 1/20 0.37
GABRA1 P14867 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24802456 0.86 AMY1A (0.49) TRPA1CSNK2A1MAPTALDH1A1PCNA
SCHEMBL3228305 0.81 SRC (0.62) SRCTRPA1CSNK2A1MPLMAPT
SCHEMBL29481933 0.81 SRC (0.62) SRCTRPA1CSNK2A1MPLMAPT
SCHEMBL5841760 0.81 SRC (0.49) SRCTRPA1NPC1RAB9ACSNK2A1
SCHEMBL30455348 0.81 POLB (0.46) ALDH1A1POLBPCNAALOX15KDM4E
SCHEMBL6583519 0.81 SRC (0.39) SRCNPC1RAB9AMAPTALDH1A1
SCHEMBL27500492 0.80 TAAR1 (0.44) SRCNPC1RAB9AMAPTPOLB
SCHEMBL24803642 0.78 TRPA1 (0.44) TRPA1MAPTALDH1A1ALOX15SMN1; SMN2
SCHEMBL24802459 0.78 MEN1 (0.45) ALDH1A1POLBCYP3A4
SCHEMBL21437740 0.77 EGFR (0.48) SRCMAPTALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed
EP-0784052-B1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation AVENTIS HOLDINGS INC (US) 2004-09-01 EP disclosed
EP-0784052-A1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1997-07-16 EP disclosed
US-4920131-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed
US-4918081-A Quinoline derivatives and use thereof as antagonists of leukotriene d4 RORER PHARMACEUTICAL CORP. (US) 1990-04-17 US disclosed
WO-1989012629-A1 QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-12-28 WO disclosed
WO-1989012628-A1 QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-12-28 WO disclosed
EP-0348155-A1 Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-12-27 EP disclosed